Belpointe Asset Management’s Calidi Biotherapeutics CLDI Stock Holding History

Belpointe Asset Management’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.76K	Sell	19,921 -50	-0.3%	-$38	﹤0.01%	1066
2025 Q4	$23.4K	Sell	19,971 -21,671	-52%	-$31.9K	﹤0.01%	1015
2025 Q3	$63.3K	Buy	41,642 +20,823	+100%	+$88.4K	﹤0.01%	966
2025 Q2	$57.5K	Hold	20,819	–	–	﹤0.01%	917
2025 Q1	$141K	Buy	+20,819	New	+$237K	0.01%	879

Other funds holding CLDI

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Warberg Asset Management Winnetka, Illinois $343M AUM 23.37% 1-Year Est. Return

HighTower Advisors

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM